What Researchers Did
Researchers conducted a systematic review of 10 articles to understand the causes, patient characteristics, symptoms, and treatments for fungal malignant otitis externa (FMOE).
What They Found
The review analyzed 197 patients with FMOE, finding a mean age of 65.9 years and 72.6% were male. A high percentage (78.7%) had underlying conditions that weakened their immune system. While 87.3% received antifungal medications, 17.3% of patients also underwent hyperbaric oxygen therapy, and the overall mortality rate was 4%.
What This Means for Canadian Patients
Canadian patients, especially those with weakened immune systems like diabetes or undergoing chemotherapy, should be aware of the risk of FMOE. Early diagnosis and appropriate treatment, which may include antifungals and potentially hyperbaric oxygen therapy, are crucial for better outcomes. Recognizing symptoms promptly can help reduce the risk of severe complications and mortality.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This systematic review was limited by the small number of available studies (10 articles) on a rare condition, which might affect the generalizability of the findings.